Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, November 8, 2019
[ Fri, Nov 08th 2019
] - WOPRAI
[ Fri, Nov 08th 2019
] - WOPRAI
[ Fri, Nov 08th 2019
] - WOPRAI
[ Fri, Nov 08th 2019
] - WOPRAI
[ Fri, Nov 08th 2019
] - WOPRAI
[ Fri, Nov 08th 2019
] - WOPRAI
[ Fri, Nov 08th 2019
] - WOPRAI
Thu, November 7, 2019
[ Thu, Nov 07th 2019
] - WOPRAI
[ Thu, Nov 07th 2019
] - WOPRAI
[ Thu, Nov 07th 2019
] - WOPRAI
[ Thu, Nov 07th 2019
] - WOPRAI
[ Thu, Nov 07th 2019
] - WOPRAI
[ Thu, Nov 07th 2019
] - WOPRAI
[ Thu, Nov 07th 2019
] - WOPRAI
[ Thu, Nov 07th 2019
] - WOPRAI
[ Thu, Nov 07th 2019
] - WOPRAI
[ Thu, Nov 07th 2019
] - WOPRAI
[ Thu, Nov 07th 2019
] - WOPRAI
[ Thu, Nov 07th 2019
] - WOPRAI
[ Thu, Nov 07th 2019
] - WOPRAI
[ Thu, Nov 07th 2019
] - WOPRAI
[ Thu, Nov 07th 2019
] - WOPRAI
[ Thu, Nov 07th 2019
] - WOPRAI
[ Thu, Nov 07th 2019
] - WOPRAI
[ Thu, Nov 07th 2019
] - WOPRAI
[ Thu, Nov 07th 2019
] - WOPRAI
Annabel Samimy Downgraded (SUPN) to Hold and Decreased Target to $23 on, Nov 7th, 2019
Annabel Samimy of Stifel, Downgraded "Supernus Pharmaceuticals, Inc." (SUPN) to Hold and Decreased Target from $55 to $23 on, Nov 7th, 2019.
Annabel has made no other calls on SUPN in the last 4 months.
There is 1 other peer that has a rating on SUPN. Out of the 1 peers that are also analyzing SUPN, all agrees with Annabel's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- David Steinberg of "Jefferies" Downgraded from Strong Buy to Hold on, Wednesday, November 6th, 2019
